When treating locally advanced nasopharyngeal carcinoma with chemoradiation, do you offer adjuvant, induction, or no additional chemotherapy beyond standard chemoradiation?   

How do you decide?  Do the results of recently published phase III data in the Lancet Oncology (Sun et al, Sept 2016) influence your decision making?  



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Kaiser Permanente
Does the results of the NEJM induction with cis/ge...
Radiation Oncologist at Memorial Sloan Kettering Cancer Center
No. The NEJM trial just informs us that if we were...
Sign in or Register to read more